Lauren Santye, Assistant Editor

Rates of suicide elevated in cancer survivors diagnosed before the age of 25 years.

Jury declares Merck’s acquired HCV drug patent valid.

The biosimilar epoetin was well-tolerated in elderly cancer patient populations.

FDA-approved drug could reduce the risk of death in adults with diabetes and cardiovascular disease.

Top news of the day from across the health care landscape.

Jardiance could reduce the risk of death in adults with diabetes and cardiovascular disease.

Attacking lung cancer cell foundation may present effective treatment option.

Study cautions against unintended consequences of “shock and kill” treatment for HIV.

New findings may lead to therapeutic options for stopping lung cancer cells from spreading to different parts of the body.

Top news of the day from across the health care landscape.

Treatment with Tecentriq helps successfully clear advanced lung cancer.

Alcohol could cause 7100 annual cancer deaths by 2035.

Blood test helps predict how aggressive lung cancer patients will respond to treatment.

Top news of the day from across the health care landscape.

Interim findings further support the efficacy, safety, and tolerability of Abraxane in NSCLC.

Abraxane shows promise in hard-to-treat non-small cell lung cancer patients.

Top news of the day from across the health care landscape.

Individuals with a history of cigarette smoking may benefit from regular ibuprofen use.

The proportion of specific inflammatory proteins can influence treatment outcomes.

Top news of the day from across the health care landscape.

Checkpoint inhibitor resistance remains an issue in cancer therapy.

Disrupting the body’s circadian clock can increase the risk of serious diseases, such as cancer.

Myeloma Genome Project to create the largest dataset of molecular profiling for patients with multiple myeloma.

In a phase 3 trial, Gazyva showed superior progression-free survival in previously untreated follicular lymphoma.

Research suggests cancer cells may evade treatment by eating adult stem cells.

Gazyva is an engineered monoclonal antibody designed to attach to CD20.

Top news of the day from across the health care landscape.

TIP60 levels could serve as a prognostic marker of breast cancer progression.

Electrodes placed into a paralyzed patient’s brain enabled her to operate a speech computer wirelessly.

An investigational drug was found to reverse the activity of immune suppressor cells.